With the election behind us, it’s time to lift healthcare above campaign rhetoric and invest in a care economy that breaks the cycle of chronic illness to build longer, healthier lives for all Americans. The post The People Behind America’s Health appeared first on MedCity News.
We’ve all read the stories and seen the images: The life-threatening heat waves. The wildfires of unprecedented ferocity. The record-breaking storms washing away entire neighborhoods. The melting glaciers, the rising sea levels, the coastal flooding. As California wildfires stretch into the colder months and hurricane survivors sort through the ruins left by floodwaters, let’s talk…
Robert Krayn is the CEO and & Dr. Georgia Caveras the CMO of Talkiatry. Robert and Georgia are quite the dynamic duo (she says, “He’s the money I’m the medicine!”). As a relative latecomer in the online mental health world, Talkiatry is trying to differentiate itself from the other big players like Lyra, Headspace, Brightside…
That is what an analysis from PwC finds, at least with respect to stock market returns. Our PwC equal-weight index of 50 pharma companies analyzes the sector’s total shareholder returns performance relative to the S&P 500 Equal Weighted Index. From 2018 through November 2024, the PwC pharma index returned 7.6% to shareholders, compared with more…
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say. The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.
Neuroflow acquired Intermountain Health’s behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support. The post Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow appeared first on…
This interactive map shows the increase in states with laws restricting abortion coverage in Medicaid and private insurance since 2010.
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagos’s headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B appeared first on MedCity News.
Leader of one of the largest hospital-at-home programs calls it ‘one of the most disruptive elements of care delivery that we’ve had in a generation’
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO market’s return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on…